Navigation Links
StemCyte Chief Scientific Officer to Present Company Overview with Focus on Indian Joint Venture at TiEcon 2008
Date:5/16/2008

COVINA, Calif., May 16 /PRNewswire/ -- StemCyte Inc. today announced that Chief Scientific Officer Ram Bhat, Ph.D., will present a company overview with a focus on the StemCyte's Indian joint venture at the TiEcon 2008 conference in Santa Clara, Calif.

Bhat will present during the session on "Stem Cells - The Future Promise and the Current State of the Art" on Saturday, May 17. His presentation will include information about the development of StemCyte India Therapeutics, the joint venture with Apollo Hospitals and Cadila Pharmaceuticals. StemCyte India Therapeutics, which was formed in March 2008, will provide stem cell therapies derived from umbilical cord blood to treat patients in India and other areas of the world.

"StemCyte India Therapeutics will enable us to develop our existing umbilical cord blood stem cell product for greater application in the Indian populations globally," said Bhat. "We are excited for the opportunity to discuss our plans for this facility with scientific leaders, entrepreneurs, and investors who attend this prestigious conference."

About StemCyte

StemCyte Inc. is a global cell therapy company with a focus on umbilical cord blood (UCB) stem cells. Since 2001, the company's stem cell products have been used to successfully treat more than 600 patients suffering from life-threatening diseases and conditions. StemCyte also has a leadership position in the development of new cell therapies in high-growth areas with the greatest clinical need. The company is accredited by AABB (formerly the American Association of Blood Banks) and Foundation for the Accreditation of Cellular Therapy (FACT). For more information, visit http://www.stemcyte.com .

StemCyte Media Contacts:

Russo Partners LLC

Ian Stone

(619) 814-3510

ian.stone@russopartnersllc.com

David Schull

(212) 845-4271

david.schull@russopartnersllc.com


'/>"/>
SOURCE StemCyte Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. StemCyte Locates East Coast Operations in New Jersey
2. NeuroFocus Chief Science Advisor Wins Humboldt Prize
3. LifeNet Health Chief Scientific Officer Wins Award
4. Pulmo BioTech Announces Appointment of Chief Financial Officer
5. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
6. Nephros Appoints Gerald J. Kochanski as Chief Financial Officer
7. Alfacell Announces Retirement of Chief Executive Officer
8. US Oncology Announces Resignation of Chief Financial Officer
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... platforms, announced today that the company has engaged in a collaborative research partnership ... (MRDA) with the CSU Office of the Vice President for Research. This agreement ...
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
(Date:12/5/2016)... 2016  Renova™ Therapeutics, a biotechnology company developing ... other chronic diseases, announced that Catherine Bovenizer ... Financial Officer (CFO), effective today. Ms. ... experience in financial management for a variety of ... Most recently, Ms. Bovenizer was the Vice President ...
Breaking Biology Technology:
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/24/2016)... 23, 2016 Cercacor today introduced Ember TM ... trainers non-invasively measure hemoglobin, Oxygen Content, Oxygen ... Respiration Rate in approximately 30 seconds. Smaller than a ... immediate access to key data about their bodies to ... regimen. Hemoglobin carries oxygen to muscles. ...
Breaking Biology News(10 mins):